Targeting CXCR4/CXCL12 axis via [177Lu]Lu-DOTAGA.(SA.FAPi)2 with CXCR4 antagonist in triple-negative breast cancer Guangfa BaoZiqiang WangXiaohua Zhu Original Article Open access 08 April 2024
An ultra-small organic dye nanocluster for enhancing NIR-II imaging-guided surgery outcomes Yajun WangDing ZhouShoujun Zhu Original Article 06 April 2024
Highlights of the 36th EANM Annual Congress 2023, from hometown Vienna, Austria: “A SYMPHONY OF SCIENCE” David KerstingSilvia MorbelliHein J. Verberne Editorial 04 April 2024 Pages: 1800 - 1808
Optimizing the pharmacokinetics of an 211At-labeled RGD peptide with an albumin-binding moiety via the administration of an albumin-binding inhibitor Hiroaki EchigoMasayuki MunekaneKazuma Ogawa Original Article Open access 04 April 2024
Latent phosphaturic mesenchymal tumor in left planta detected by [18F]F-AlF-NOTA-octreotide PET/CT Congcong YuLin ChenHong Zhang Image of the Month 03 April 2024
Initial [18F]DCFPyL PET/CT in treatment-naïve prostate cancer: correlation with post-ADT PSA outcomes and recurrence Yuekai LiShiwei WangXiang Li Short Communication 02 April 2024 Pages: 2458 - 2466
Disrupted gut microecology after high-dose 131I therapy and radioprotective effects of arachidonic acid supplementation Ganghua LuDingwei GaoZhongwei Lv Original Article Open access 02 April 2024 Pages: 2395 - 2408
Targeted interleukin-2 enhances the in vivo anti-cancer activity of Pluvicto™ Tony GeorgievLucrezia PrincipiSamuele Cazzamalli Short Communication 02 April 2024 Pages: 2332 - 2337
The status of nuclear medicine in China: the first official national survey Haiqiong ZhangJin ZhengLi Huo Original Article 02 April 2024 Pages: 2172 - 2178
Clinical translation of a novel FAPI dimer [68Ga]Ga-LNC1013 Yue TanJian LiJingjing Zhang Original Article 02 April 2024
The effect of prednisolone and a short-term prednisolone discontinuation for the diagnostic accuracy of FDG-PET/CT in polymyalgia rheumatica—a prospective study of 101 patients Andreas Wiggers NielsenIb Tønder HansenKresten Krarup Keller Original Article Open access 02 April 2024
Diagnostic imaging of the diabetic foot: an EANM evidence-based guidance Chiara LauriEdel Noriega-ÁlvarezAlberto Signore Original Article Open access 27 March 2024 Pages: 2229 - 2246
Macrophage mannose receptor CD206 targeting of fluoride-18 labeled mannosylated dextran: A validation study in mice Putri AndrianaRuth Fair-MäkeläAnne Roivainen Original Article Open access 27 March 2024 Pages: 2216 - 2228
Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumours Seval Beykan SchürrleUta EberleinMichael Lassmann Original Article Open access 26 March 2024 Pages: 2428 - 2441
Whole-body tumour burden on [18F]DCFPyL PET/CT in biochemical recurrence of prostate cancer: association with tumour biology and PSA kinetics Laura García-ZoghbyMariano Amo-SalasAna María García Vicente Original Article 23 March 2024 Pages: 2467 - 2483
Correction to: A bis-boron boramino acid PET tracer for brain tumor diagnosis Zhu LiJunyi ChenZhibo Liu Correction 22 March 2024 Pages: 1796 - 1797
The superior detection rate of total-body [68Ga]Ga-PSMA-11 PET/CT compared to short axial field-of-view [68Ga]Ga-PSMA-11 PET/CT for early recurrent prostate cancer patients with PSA < 0.2 ng/mL after radical prostatectomy Yining WangLiang DongRuohua Chen Original Article 22 March 2024 Pages: 2484 - 2494
Image-based dosimetry for [225Ac]Ac-PSMA-I&T therapy and the effect of daughter-specific pharmacokinetics Grigory LiubchenkoGuido BöningAstrid Delker Original Article Open access 21 March 2024 Pages: 2504 - 2514
A rationally designed nuclei-targeting FAPI 04-based molecular probe with enhanced tumor uptake for PET/CT and fluorescence imaging Xingyang ZhaoGuojin ZhangLiming Nie Original Article 21 March 2024 Pages: 1593 - 1604
“Metabolic fingerprints” of cachexia in lung cancer patients Armin FrilleJann Arends(the LuCaPET consortium) Letter to the Editor Open access 20 March 2024 Pages: 2067 - 2069
Near-infrared II theranostic agents for the diagnosis and treatment of Alzheimer’s disease Can ZhouFantian ZengJian Yang Review Article 19 March 2024
Non-invasive assessment of stimulation-specific changes in cerebral glucose metabolism with functional PET Godber Mathis GodbersenPia FalbAndreas Hahn Original Article Open access 16 March 2024 Pages: 2283 - 2292
Challenges coexist with opportunities: development of a macrocyclic peptide PET radioligand for PD-L1 Wenpeng HuangMai Hong SonWeibo Cai Editorial 16 March 2024 Pages: 1574 - 1577
Early detection of anthracycline-induced cardiotoxicity using [68 Ga]Ga-FAPI-04 imaging Zhuxin WeiHongchuang XuShihua Zhao Original Article 16 March 2024 Pages: 2204 - 2215
Radiofrequency ablation versus radioactive iodine: the race for the best cure Fabio VolpeCarmela NappiMichele Klain Editorial 15 March 2024 Pages: 2047 - 2049
ImmunoPET/CT imaging of clear cell renal cell carcinoma with [18F]RCCB6: a first-in-human study Qianyun WuYanfei WuWeijun Wei Original Article 14 March 2024 Pages: 2444 - 2457
Diagnostic and prognostic value of dual-point amyloid PET in Alzheimer’s disease (AD) mimickers Luca SofiaFederico MassaSilvia Morbelli Image of the Month Open access 14 March 2024
[177Lu]Lu-PSMA-617 as first-line systemic therapy in patients with metastatic castration-resistant prostate cancer: a real-world study Swayamjeet SatapathyMadhav Prasad YadavChandrasekhar Bal Original Article 12 March 2024 Pages: 2495 - 2503
[18F]FDG PET/CT for prognosis and toxicity prediction of diffuse large B-cell lymphoma patients with chimeric antigen receptor T-cell therapy Jinbo GuiMengting LiXiaoli Lan Original Article 12 March 2024 Pages: 2308 - 2319
[68Ga]Ga-FAPI versus [18F]FDG PET/CT in the evaluation of Langerhans cell histiocytosis Linlin GuoGuohua Shen Image of the Month 09 March 2024 Pages: 2520 - 2521
PET imaging of PD-L1 with a small molecule radiotracer Yajie ZhaoJessica C. HsuWeibo Cai Editorial 09 March 2024 Pages: 1578 - 1581
Guiding principles on the education and practice of theranostics Thomas N. B. PascualDiana PaezAndrew M. Scott Original Article Open access 08 March 2024 Pages: 2320 - 2331
Artificial intelligence–based, volumetric assessment of the bone marrow metabolic activity in [18F]FDG PET/CT predicts survival in multiple myeloma Christos SachpekidisOlof EnqvistAntonia Dimitrakopoulou-Strauss Original Article Open access 08 March 2024 Pages: 2293 - 2307
Thoracic aortic microcalcification activity in combined positron emission tomography and magnetic resonance imaging Jennifer NashSamuel DebonoAlexander J Fletcher Original Article Open access 08 March 2024 Pages: 2260 - 2270
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([161Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum Julia FrickeFrida WesterberghDamian Wild Image of the Month Open access 07 March 2024 Pages: 2517 - 2519
Preoperative evaluation of mediastinal lymph nodes in non-small cell lung cancer using [68Ga]FAPI-46 PET/CT: a prospective pilot study Yeon-koo KangKwon Joong NaYoung Tae Kim Original Article Open access 07 March 2024 Pages: 2409 - 2419
Preclinical validation of a novel brain-penetrant PET ligand for visualization of histone deacetylase 6: a potential imaging target for neurodegenerative diseases Tetsuro TagoMuneyuki SakataJun Toyohara Original Article 05 March 2024 Pages: 2193 - 2203
Tau aggregation following subcortical hemorrhage Elena JaegerGérard N. BischofAlexander Drzezga Image of the Month Open access 04 March 2024 Pages: 2515 - 2516
Expanding the long-axial field-of-view PET-CT horizons: unveiling new arrows in our quiver Andrea PonsiglioneCarmela NappiMichele Klain Editorial 04 March 2024 Pages: 2098 - 2099
More than meets the eye: 2-[18F]FDG PET-based radiomics predicts lymph node metastasis in colorectal cancer patients to enable precision medicine Wenpeng HuangMai Hong SonWeibo Cai Editorial 01 March 2024 Pages: 1725 - 1728
Homodimeric peptide radiotracer [68Ga]Ga-NOTA-(TMVP1)2 for VEGFR-3 imaging of cervical cancer patients Xi ChenZhenzhong ZhangLing Xi Original Article 27 February 2024 Pages: 2338 - 2352
Altered biodistribution of [68Ga]Ga-DOTA-TOC during somatostatin analogue treatment T. van de WeijerF. BemerF. M. Mottaghy Original Article Open access 26 February 2024 Pages: 2420 - 2427
Internal dosimetry study of [82Rb]Cl using a long axial field-of-view PET/CT Lorenzo MercolliCarola BregenzerFederico Caobelli Short Communication Open access 26 February 2024 Pages: 1869 - 1875
Enhancing predictability of IDH mutation status in glioma patients at initial diagnosis: a comparative analysis of radiomics from MRI, [18F]FET PET, and TSPO PET Lena KaiserS. QuachN. L. Albert Original Article Open access 24 February 2024 Pages: 2371 - 2381
Exploring the nigrostriatal and digestive interplays in Parkinson’s disease using dynamic total-body [11C]CFT PET/CT Mei XinYihan WangJianjun Liu Original Article 23 February 2024 Pages: 2271 - 2282
EANM practice guidelines for an appropriate use of PET and SPECT for patients with epilepsy Tatjana Traub-WeidingerJavier ArbizuFranck Semah Guidelines Open access 23 February 2024 Pages: 1891 - 1908
Letter to the Editor: FDG Liver Biodistribution Dale L. BaileyGeoffrey P. SchembriPaul J. Roach Letter to the Editor 23 February 2024 Pages: 1213 - 1214
FDG imaging with long-axial field-of-view PET/CT in patients with high blood glucose—a matched pair analysis Clemens MingelsLuis WeissenriederThomas Pyka Original Article Open access 22 February 2024 Pages: 2036 - 2046
Intelligent ultrafast total-body PET for sedation-free pediatric [18F]FDG imaging Xiang ZhouYu FuKuangyu Shi Original Article 22 February 2024 Pages: 2353 - 2366
Effectiveness of [67Cu]Cu-trastuzumab as a theranostic against HER2-positive breast cancer Jessica Pougoue KetchemenFabrice Ngoh NjotuHumphrey Fonge Original Article 20 February 2024 Pages: 2070 - 2084